Lipoid Team Visits Inno Medicine to Strengthen Technical Cooperation Between Strategic Partners

On June 13, Mr. Balder Rebmann, the Global Marketing Director of Lipoid, our strategic partner in Germany, led a team to visit Inno Medicine. Chairperson and CEO Dr. Ma Qian, COO Ms. Ji Fengyuan, and other management team members received the guests and guided them through a company tour.

On behalf of the compamy, Fengyuan gave a presentation about the history of Inno Medicine, the current status of pipeline development, and the Company's future plans. She shared with the guests that Inno Medicine has developed an active targeted nano-drug delivery platform and has formed a comprehensive intellectual property system. Focusing on the tremendous unmet clinical needs, the Company fully leverages its clinical and commercial manufacturing resources to expedite the discovery, development, and commercialization of novel drugs. At present, Inno Medicine has independently developed product pipelines targeting various therapeutic areas, including cardiovascular diseases and brain glioma. Inno Medicine upholds the mission “innovation for a healthier world”, along with cultural values rooted in benevolence and unwavering dedication to perfection. The Company has established its headquarters office and R&D center in Beijing, a GMP-compliant manufacturing facility in Shanghai, and a clinical study center in Australia. The Lipoid team highly commended Inno Medicine's capabilities in product development as well as process development, and the corporate values and culture. Mr. Rebmann remarked that Lipoid is a world-leading supplier of highly pure phospholipids, and a pioneer in embracing high-quality standards. These standards are regarded as industry norms and are adopted by regulators of many countries in their pharmacopeia.

The visit by the Lipoid senior executive team marks a promising beginning for future collaboration between the two companies in clinical development and commercial sourcing. This strategic partnership will propel Inno Medicine to enhance its product pipeline in compliance with international standards, and further accelerate the commercialization of its R&D outcomes.

Dr. Ma Qian and the Inno Medicine Management Team with Lipoid Executives

About Lipoid Group

Headquartered in Germany, Lipoid Group is the world's only supplier to produce the whole spectrum of natural, hydrogenated, and highly pure synthetic phospholipids. Phospholipids provide the essential basis for sophisticated parenteral drug delivery systems such as liposomes, mixed micelles, and lipid nanoparticles. Lipoid Group enables commercialization of such complex formulations through provision of phospholipids.